| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.7M | +251.1% |
| R&D Expense | $766K | — |
| SG&A Expense | $18.1M | +43.3% |
| Operating Income | -$33.7M | -61.4% |
| Interest Expense | $7.0M | +1998.5% |
| Pre-tax Income | -$29.3M | -91.1% |
| Income Tax | -$949K | -581.9% |
| Net Income | -$28.4M | -86.6% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $849K | -84.8% |
| Total Assets | $265.6M | +266.2% |
| Total Liabilities | $338.6M | +175.0% |
| Stockholders' Equity | -$72.9M | -44.2% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$56.7M | -265.8% |
| Capital Expenditures | $65K | +63.7% |
| Investing Cash Flow | $96K | -40.3% |
| Financing Cash Flow | $51.6M | +348.5% |
| Free Cash Flow | -$56.7M | -265.2% |